Omnix Medical Ltd.
PrivateLast Round
Grant
Jul 13, 2026
Total Funding Raised
$57.26M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Omnix Medical Ltd. operates in Healthcare & Life Sciences and is based in Jerusalem. Its latest recorded funding round was a Grant round in July 2026.
Omnix Medical Ltd. is a biopharmaceutical company that develops next-generation antimicrobial peptides to treat drug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omnix Medical Ltd. Comparables
Compare Omnix Medical Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VenatoRx Pharmaceuticals | 86% | |
| Antabio | 83% | |
| Bugworks Research Inc. | 79% |
For institutional investors. Book with your work email.
Omnix Medical Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 13, 2026 | ||||
| Series C | Oct 15, 2025 | ||||
| Grant | Jan 25, 2021 | ||||
| Series A | Nov 3, 2020 | ||||
| Seed | Dec 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Omnix Medical Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Tal Ventures | Series A |
| European Innovation Council Fund | Grant, Series C |
| Israel Innovation Authority | Series A, Seed |
| Entrée Capital | Series C, Series A |
| Tal Ventures | Series C, Series A |
| Xenia Venture Capital | Series A, Series C, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 4, 3.3x the trailing average.
- Jul 13, 2026
$9.15M grant received from Horizon Europe (Euratom).
For institutional investors. Book with your work email.
Omnix Medical Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Omnix Medical Ltd.'s valuation, stock price, and market status.
Is Omnix Medical Ltd. a public or private company?
Omnix Medical Ltd. is a private company.
What is the current stock price of Omnix Medical Ltd.?
Omnix Medical Ltd. is a private company, so its shares have no public market price. Caplight tracks Omnix Medical Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omnix Medical Ltd. worth (valuation)?
Valuation information for Omnix Medical Ltd. is not publicly available.
Can I buy Omnix Medical Ltd. stock?
Omnix Medical Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omnix Medical Ltd.'s last funding round?
Omnix Medical Ltd.'s most recent funding round was Grant on July 13, 2026.
Who are the main investors in Omnix Medical Ltd.?
Key investors in Omnix Medical Ltd. include Tal Ventures, European Innovation Council Fund, Entrée Capital, Tal Ventures, Harel Insurance Investments & Financial Services.
Will Omnix Medical Ltd. IPO soon?
No public IPO plans have been announced for Omnix Medical Ltd..
How can I track Omnix Medical Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Omnix Medical Ltd.'s shares on secondary markets.